Candriam SCA’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.4M Sell
345,399
-11,576
-3% -$615K 0.11% 181
2025
Q1
$15.5M Sell
356,975
-4,688
-1% -$203K 0.1% 189
2024
Q4
$20.3M Sell
361,663
-94,928
-21% -$5.33M 0.12% 165
2024
Q3
$31.1M Buy
456,591
+244,064
+115% +$16.6M 0.18% 122
2024
Q2
$8.98M Buy
212,527
+15,774
+8% +$666K 0.05% 269
2024
Q1
$13.6M Sell
196,753
-81,917
-29% -$5.66M 0.09% 219
2023
Q4
$20.6M Buy
278,670
+131,582
+89% +$9.73M 0.14% 156
2023
Q3
$10M Buy
147,088
+137,169
+1,383% +$9.36M 0.07% 230
2023
Q2
$931K Sell
9,919
-7,267
-42% -$682K 0.01% 609
2023
Q1
$1.07M Buy
17,186
+5,251
+44% +$328K 0.01% 691
2022
Q4
$591K Sell
11,935
-114,324
-91% -$5.66M ﹤0.01% 791
2022
Q3
$4.1M Buy
126,259
+118,424
+1,511% +$3.85M 0.03% 424
2022
Q2
$309K Sell
7,835
-4,423
-36% -$174K ﹤0.01% 758
2022
Q1
$857K Sell
12,258
-224,575
-95% -$15.7M 0.01% 680
2021
Q4
$18.4M Buy
236,833
+5,974
+3% +$465K 0.12% 187
2021
Q3
$22M Sell
230,859
-8,133
-3% -$776K 0.15% 159
2021
Q2
$29.7M Buy
238,992
+63,118
+36% +$7.85M 0.2% 117
2021
Q1
$22.4M Sell
175,874
-2
-0% -$255 0.19% 136
2020
Q4
$23.3M Sell
175,876
-66,704
-27% -$8.84M 0.18% 137
2020
Q3
$24.7M Buy
242,580
+54,652
+29% +$5.57M 0.23% 102
2020
Q2
$16.3M Buy
187,928
+71,571
+62% +$6.22M 0.17% 147
2020
Q1
$10.5M Buy
116,357
+25
+0% +$2.26K 0.12% 204
2019
Q4
$10.8M Buy
116,332
+61,690
+113% +$5.7M 0.12% 206
2019
Q3
$4.94M Buy
54,642
+20,183
+59% +$1.82M 0.07% 324
2019
Q2
$4.05M Buy
34,459
+10,700
+45% +$1.26M 0.05% 377
2019
Q1
$2.06M Buy
23,759
+18,994
+399% +$1.65M 0.03% 491
2018
Q4
$301K Buy
+4,765
New +$301K ﹤0.01% 743